Home » Newsletters » BioWorld

BioWorld

Jan. 28, 2000

View Archived Issues

Incyte Plans Notes Offering Expected To Bring In $150M

Discovery Labs Starts Phase III Of Surfaxin, Stops Other Study

Other News To Note

Insmed Raising $34M Prior To Planned Merger With Celtrix

Merck Finds Compounds That Foil Viral Enzyme's DNA Hook To Cells Targeted For Infection

Gene Logic Prices Offering, Doubling Proceeds To $222M

Allos, IntraBiotics File For IPOs To Finance Late-Stage Products